Paperless Parotograph in Evaluation of Labour (labourRecord)

September 1, 2017 updated by: ayman darder, Assiut University

Paperless Partograph Evaluation of Labour

Using Paperless partograph management of labour as simple tool to prevent obstructed labour or prolonged labour or its complications at the mother or her fetus

Study Overview

Status

Unknown

Conditions

Detailed Description

WHO PARTOGRAPH is very work load need more time and more stuff in both treaning and learning for plotting and for drowning but inside labour room needing simple partograph playing the simple partograph beast role in management of labour and stand test against time for saving live of labour women and her child Paperless parotograph can help obestitricianes to talk decision about when to transferr the labourus women to higher centers on to make medical intervention or what time to end labour by caesarian section

Study Type

Observational

Enrollment (Anticipated)

450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Assiut, Egypt, 71723
        • Recruiting
        • Faculity of Medicine
        • Contact:
          • abobaker khalil abass metwally, professor
          • Phone Number: 002010033568474
          • Email: kotbnetw@hotmail.com
        • Contact:
        • Principal Investigator:
          • ayman darder abed algwad mohamed, specialest
    • Assiut
      • Asyūţ, Assiut, Egypt, 71723
        • Recruiting
        • Faculity of Medicine Assiut University
        • Contact:
        • Contact:
        • Principal Investigator:
          • ayman darder, dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 42 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

By following women during labour using well structured questions developed by researcher and filling well designed Paperless partograph stumped THE collected data will be analysed using special computer program SPSS tactical program for social science

Description

Inclusion Criteria:

  • women ln active phase of labour
  • With single pregnanncy
  • living fetus
  • cephalic presentation
  • occipt anterior
  • 36 weak gestional age up to full term

Exclusion Criteria:

  • preterm . .or women with antipartum hemorrhage .
  • or multipregnanncy
  • previous utrine surgery
  • or abnormal cardiotocograph(CTG )PATTERN
  • or any heart disease of mother or his fetus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Crossover
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Progress of labour
Time Frame: up to 5 months
Cervical dilatation 1 cm / hour
up to 5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Charcteristics of new_born
Time Frame: up to 1 month
Apgar score at1minute and Apgar score at 5minutes
up to 1 month
Time taken after ALERT EDT
Time Frame: up to 2 months
Primgravida and Multipara
up to 2 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mode of delivery
Time Frame: up to 9 weeks
Normal vaginal delivery or caesarean section
up to 9 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Study Director: mohamed khalaph, assiut universty faculity of medicine
  • Study Chair: ahmad abass, assiut university faclity of meficibe

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2017

Primary Completion (Anticipated)

September 12, 2017

Study Completion (Anticipated)

September 12, 2017

Study Registration Dates

First Submitted

August 23, 2017

First Submitted That Met QC Criteria

August 31, 2017

First Posted (Actual)

September 5, 2017

Study Record Updates

Last Update Posted (Actual)

September 6, 2017

Last Update Submitted That Met QC Criteria

September 1, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • paperlesspartograph

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Study Data/Documents

  1. Study Protocol
    Information identifier: prospective auther of journals
    Information comments: All the journals articles are amiable online to the reader all over the world without financially legal barriers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Complication

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe